bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule [Pylera]

RxCUI: 1294621
RxNorm name: bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule [Pylera]
Display name: bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule [Pylera]
Full name: bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule [Pylera]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
PYLERA	BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE	H2-Pharma, LLC	5cdacbf5-67be-42eb-bd54-8acc32ea1abc	2026-06-29	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1294621
PYLERA	BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE	H2-Pharma, LLC	c50626a2-5969-490b-a88a-a4ee45e79615	2026-01-16	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1294621

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
c50626a2-5969-490b-a88a-a4ee45e79615	PYLERA 140 MG / 125 MG / 125 MG Oral Capsule [PSN] · bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule [Pylera] [SBD] · Pylera (bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG) Oral Capsule [SY]	3	4	These highlights do not include all the information needed to use PYLERA safely and effectively. See full prescribing information for PYLERA. PYLERA® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) capsules, for oral use Initial U.S. Approval: 2006	20260116
5cdacbf5-67be-42eb-bd54-8acc32ea1abc	PYLERA 140 MG / 125 MG / 125 MG Oral Capsule [PSN] · bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule [Pylera] [SBD] · Pylera (bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG) Oral Capsule [SY]	3	3	These highlights do not include all the information needed to use PYLERA safely and effectively. See full prescribing information for PYLERA. PYLERA ® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) capsules, for oral use Initial U.S. Approval: 2006	20250407
7fe5d2db-c59d-4e15-acd7-f9df8eca45aa	PYLERA 140 MG / 125 MG / 125 MG Oral Capsule [PSN] · bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule [Pylera] [SBD] · Pylera (bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG) Oral Capsule [SY]	3	1	These highlights do not include all the information needed to use PYLERA safely and effectively. See full prescribing information for PYLERA. Initial U.S. Approval: 2006	20110203